Tanda Stephan B. sold $1.3M of ATR

Tanda Stephan B. (President and CEO) sold 9,838 shares of APTARGROUP, INC. (ATR) at $136.16 ($1.34M total) on 2026-08-03.

Original reporting
SEC EDGAR · Tanda Stephan B.
Published Aug 4, 2026, 2:37 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 4, 2026, 2:39 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ATR
Neutral
medium confidence
Mentioned
$ATR
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATRNeutralLow
01

Why it matters

The newest disclosed fact is the CEO’s open-market sale details (shares, price, total value, and remaining holdings). This can influence short-term sentiment but is not a fundamental update.

02

Market read

Traders may monitor ATR for follow-on insider activity, but this specific disclosure alone is unlikely to drive a sustained repricing.

03

What to watch

The filing explicitly notes no pre-arranged 10b5-1 plan, but it still does not reveal the reason for sale or whether other insiders are trading.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-04, sale dated 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for AptarGroup, Inc. (ATR).

Company-level read

Ticker impact

$ATRNeutralMedium confidence
Context

SEC Form 4 shows ATR CEO Tanda Stephan B. sold 9,838 shares for about $1.34M at $136.1647 on 2026-08-03.

Expected impact

Likely limited near-term impact; any reaction should be small and fade unless accompanied by other news.

Evidence & confidence

The filing discloses transaction size, price, and post-sale holdings, but provides no new company performance, guidance, or material event.

Market effects

No clear sector read-through from a single insider sale.

None indicated.

None indicated.

Counterpoint

Insider sales can be driven by diversification, taxes, or pre-planned liquidity needs, so the signal may be overstated.

Key entities

  • AptarGroup, Inc.

    Company whose CEO filed an SEC Form 4 reporting an open-market sale.

  • Tanda Stephan B.

    President and CEO who sold 9,838 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATRHighAI 8/10

Aptar Q3 2026 slides: broad growth, strong Pharma pipeline

AptarGroup (NYSE:ATR) reported Q3 2026 sales of $1.019B, up 6% YoY, with adjusted EPS of $1.52 beating estimates. Growth was seen across all segments, but margins were pressured. The Pharma segment grew 2% reported, 1% core, while Beauty grew 9% reported, 8% core, and Closures grew 11%. Management expects Q4 adjusted EPS of $1.39-$1.47, up 17% YoY.

$ATRMed

AptarGroup Inc (ATR) (Q3 2026) Earnings Call Highlights: Core Sales Grow 5% as Pharma

AptarGroup Inc (ATR) reported Q3 2026 core sales growth of 5% across all segments, with Pharma, Beauty, and Closures up 8%, 8%, and 11% respectively. Adjusted EPS was $1.52, down 6% YoY. Pharma growth was impacted by emergency medicine destocking, expected to affect full-year sales by $65M. Beauty and Closures margins declined due to operational challenges. CEO Gael Touya outlined plans for multi-year transformation in Beauty and reiterated long-term growth targets for Pharma.

$ATRMedAI 8/10

What AptarGroup (ATR) Said on Its Q3 Earnings Call

AptarGroup (ATR) reported Q3 earnings, highlighting growth in beauty, closures, and pharma sectors. Beauty core sales rose 8%, while closures saw 11% growth. Pharma developments include collaborations and acquisitions. The company recorded a $61.2M charge related to its Russian subsidiary. ATR forecasted Q4 adjusted EPS of $1.39-$1.47, up 17% YoY. Full-year capex is expected at $260M-$280M. Virginie Maes will lead Aptar Pharma starting January 1.